Wockhardt Posts PAT of Rs. 107 Cr for Q1 FY27 as Biotech Portfolio Drives Growth
Wockhardt Limited, a global pharmaceutical and biotechnology company, announced its first-quarter results for the financial year 2026-27. The company reported Profit After Tax (PAT) of Rs. 107 crore for the quarter ended June 30, 2026.The consolidated Q1 FY27 performance showed significant momentum, with revenue growing by 26% compared to the previous year. Revenue reached Rs. 929 crore in Q1 FY27, up from Rs. 738 crore in the corresponding period of the prior year. EBITDA grew strongly by 86%, hitting Rs. 188 crore against a previous figure of Rs. 101 crore.The company’s portfolio highlights the increasing contribution of its innovative offerings, with...